This observational study, called the Pancreatic Adenocarcinoma Gene Environment Risk Study, aims to understand the factors that contribute to pancreatic cancer. Researchers are collecting information and samples from people with pancreatic cancer and those with other conditions affecting the pancreas, liver, or intestines. There are no specific interventions or treatments being tested in this study. The goal is to gather data over 10 years to identify connections between genes, environment, and pancreatic cancer. The study is currently recruiting a large number of participants, up to 10,000 people. To join, you must be at least 18 years old and have either a confirmed diagnosis of pancreatic adenocarcinoma (a type of pancreatic cancer) or certain other pancreatic, liver, or intestinal conditions.

Study design

This is an observational study with a planned enrollment of up to 10,000 participants. It is not testing a specific drug or treatment.

What's involved

You will be asked to complete a medical/family history questionnaire and provide a blood sample. Some participants may also provide a urine sample, and researchers may save biological samples collected during clinical procedures for research. You will also be asked for permission to access your medical records and to be recontacted for updates.

Compensation

Not stated in the trial record.

Follow-up

The data will be used in cohort association studies, with endpoints measured at 10 years.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.